ChemExpress, founded in 2006, specializes in providing small molecule and new modalities CDMO services for the pharmaceutical and biotech industry globally. Their comprehensive platform offers research, development, manufacturing, and supply of regulatory starting materials, building blocks, intermediates, APIs, and drug products. ChemExpress serves as a one-stop service platform supporting projects from early drug discovery to commercialization, focusing on services such as synthetic chemistry, medicinal chemistry, process development, manufacturing, regulatory CMC support, and various enabling technologies like biocatalysis, flow chemistry, and solid-state chemistry research.